A new deal between drug companies formed at Davos aims to step up the fight against antibiotic resistance. But is it too little too late? In January, a coalition of 85 biotechnology, pharmaceutical and diagnostics companies, including Johnson & Johnson and Pfizer, came together at the World Economic Forum in Davos to form a landmark agreement to help combat antibiotic resistance. The companies have called on governments to help fund research and aid in developing a “sustainable and predictable” market for new drugs.It’s a promising step, but there’s still a long way to go. Even when new antibiotics are discovered, Read More

Source:: The Guardian